{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:15Z","timestamp":1792025175156,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00894-026-06975-2","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:09:30Z","timestamp":1791878970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction and validation of pharmacophore model of calcitonin gene-related peptide receptor antagonists using ligand- and structure-based approaches"],"prefix":"10.1007","volume":"32","author":[{"given":"Thangaraj","family":"Devadoss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shvetank","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punniyakoti Veeraveedu","family":"Thanikachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"6975_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/298240a0","volume":"298","author":"SG Amara","year":"1982","unstructured":"Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240\u2013244. https:\/\/doi.org\/10.1038\/298240a0","journal-title":"Nature"},{"key":"6975_CR2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1161\/HYPERTENSIONAHA.120.14851","volume":"77","author":"F Argunhan","year":"2021","unstructured":"Argunhan F, Thapa D, Aubdool AA, Carlini E, Arkless K, Hendrikse ER, de Sousa Valente J, Kodji X, Barrett B, Ricciardi CA, Gnudi L, Hay DL, Brain SD (2021) Calcitonin gene-related peptide protects against cardiovascular dysfunction independently of nitric oxide in vivo. Hypertension 77:1178\u20131190. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.14851","journal-title":"Hypertension"},{"key":"6975_CR3","doi-asserted-by":"publisher","first-page":"100361","DOI":"10.1016\/j.bbih.2021.100361","volume":"18","author":"YJ Kim","year":"2021","unstructured":"Kim YJ, Granstein RD (2021) Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions. Brain Behav Immun Health 18:100361. https:\/\/doi.org\/10.1016\/j.bbih.2021.100361","journal-title":"Brain Behav Immun Health"},{"key":"6975_CR4","doi-asserted-by":"publisher","first-page":"G546","DOI":"10.1152\/ajpgi.1989.256.3.G546","volume":"256","author":"P Holzer","year":"1989","unstructured":"Holzer P, Barth\u00f3 L, Matus\u00e1k O, Bauer V (1989) Calcitonin gene-related peptide action on intestinal circular muscle. Am J Physiol 256:G546\u2013G552. https:\/\/doi.org\/10.1152\/ajpgi.1989.256.3.G546","journal-title":"Am J Physiol"},{"key":"6975_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41598-022-05518-y","volume":"12","author":"N Hashikawa-Hobara","year":"2022","unstructured":"Hashikawa-Hobara N, Yoneyama Y, Fujiwara K, Hashikawa N (2022) Intranasal calcitonin gene-related peptide administration impairs fear memory retention in mice through the PKD\/p-HDAC5\/Npas4 pathway. Sci Rep 12:1450. https:\/\/doi.org\/10.1038\/s41598-022-05518-y","journal-title":"Sci Rep"},{"key":"6975_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2008.12.007","volume":"9","author":"S Benemei","year":"2009","unstructured":"Benemei S, Nicoletti P, Capone JG, Geppetti P (2009) CGRP receptors in the control of pain and inflammation. Curr Opin Pharmacol 9:9\u201314. https:\/\/doi.org\/10.1016\/j.coph.2008.12.007","journal-title":"Curr Opin Pharmacol"},{"key":"6975_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/14728222.2020.1724285","volume":"24","author":"AS Wattiez","year":"2020","unstructured":"Wattiez AS, Sowers LP, Russo AF (2020) Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets 24:91\u2013100. https:\/\/doi.org\/10.1080\/14728222.2020.1724285","journal-title":"Expert Opin Ther Targets"},{"key":"6975_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12031-018-1202-3","volume":"67","author":"D Sanford","year":"2019","unstructured":"Sanford D, Luong L, Gabalski A, Oh S, Vu JP, Pisegna JR, Germano P (2019) An intraperitoneal treatment with calcitonin gene-related peptide (CGRP) regulates appetite, energy intake\/expenditure, and metabolism. J Mol Neurosci 67:28\u201337. https:\/\/doi.org\/10.1007\/s12031-018-1202-3","journal-title":"J Mol Neurosci"},{"key":"6975_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3389\/fphys.2018.01249","volume":"9","author":"Z Kee","year":"2018","unstructured":"Kee Z, Kodji X, Brain SD (2018) The role of calcitonin gene related peptide (CGRP) in neurogenic vasodilation and its cardioprotective effects. Front Physiol 9:1249. https:\/\/doi.org\/10.3389\/fphys.2018.01249","journal-title":"Front Physiol"},{"key":"6975_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie SJ, Kodji X, Brain SD (2014) Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev 94:1099\u20131142. https:\/\/doi.org\/10.1152\/physrev.00034.2013","journal-title":"Physiol Rev"},{"issue":"Suppl 1","key":"6975_CR11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1526-4610.2006.00483.x","volume":"46","author":"PL Durham","year":"2006","unstructured":"Durham PL (2006) Calcitonin gene-related peptide (CGRP) and migraine. Headache 46(Suppl 1):S3\u2013S8. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00483.x","journal-title":"Headache"},{"issue":"Suppl 3","key":"6975_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/head.13379","volume":"58","author":"SJ Tepper","year":"2018","unstructured":"Tepper SJ (2018) History and review of anti-calcitonin gene-related peptide (CGRP) therapies: from translational research to treatment. Headache 58(Suppl 3):238\u2013275. https:\/\/doi.org\/10.1111\/head.13379","journal-title":"Headache"},{"key":"6975_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3390\/neurolint15030067","volume":"15","author":"H Ple\u0219","year":"2023","unstructured":"Ple\u0219 H, Florian IA, Timi\u0219 TL, Covache-Busuioc RA, Glavan LA, Dumitrascu DI, Popa AA, Bordeianu A, Ciurea AV (2023) Migraine: advances in the pathogenesis and treatment. Neurol Int 15:1052\u20131105. https:\/\/doi.org\/10.3390\/neurolint15030067","journal-title":"Neurol Int"},{"key":"6975_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s40120-024-00586-w","volume":"13","author":"T Alsaadi","year":"2024","unstructured":"Alsaadi T, Suliman R, Santos V, Al Qaisi I, Carmina P, Aldaher B, Haddad S, Bader Y (2024) Safety and tolerability of combining CGRP monoclonal antibodies with gepants in patients with migraine: a retrospective study. Neurol Ther 13:465\u2013473. https:\/\/doi.org\/10.1007\/s40120-024-00586-w","journal-title":"Neurol Ther"},{"key":"6975_CR15","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/brainsci12121612","volume":"12","author":"JP Rissardo","year":"2022","unstructured":"Rissardo JP, Caprara ALF (2022) Gepants for acute and preventive migraine treatment: a narrative review. Brain Sci 12:1612. https:\/\/doi.org\/10.3390\/brainsci12121612","journal-title":"Brain Sci"},{"key":"6975_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/14737175.2022.2091435","volume":"22","author":"AA Argyriou","year":"2022","unstructured":"Argyriou AA, Mantovani E, Mitsikostas DD, Vikelis M, Tamburin S (2022) A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine. Expert Rev Neurother 22:469\u2013488. https:\/\/doi.org\/10.1080\/14737175.2022.2091435","journal-title":"Expert Rev Neurother"},{"key":"6975_CR17","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.bmcl.2010.01.012","volume":"20","author":"PL Nichols","year":"2010","unstructured":"Nichols PL et al (2010) Potent oxadiazole CGRP receptor antagonists for the potential treatment of migraine. Bioorg Med Chem Lett 20:1368\u20131372. https:\/\/doi.org\/10.1016\/j.bmcl.2010.01.012","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR18","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.1021\/acs.jmedchem.9b01810","volume":"63","author":"GM Dubowchik","year":"2020","unstructured":"Dubowchik GM, Conway CM, Xin AW (2020) Blocking the CGRP pathway for acute and preventive treatment of migraine: the evolution of success. J Med Chem 63:6600\u20136623. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01810","journal-title":"J Med Chem"},{"issue":"10","key":"6975_CR19","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/j.bmcl.2006.02.051","volume":"16","author":"TM Williams","year":"2006","unstructured":"Williams TM, Stump CA, Nguyen DN, Quigley AG, Bell IM, Gallicchio SN, Zartman CB, Wan BL, Penna KD, Kunapuli P, Kane SA, Koblan KS, Mosser SD, Rutledge RZ, Salvatore C, Fay JF, Vacca JP, Graham SL (2006) Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead. Bioorg Med Chem Lett 16(10):2595\u20132598. https:\/\/doi.org\/10.1016\/j.bmcl.2006.02.051","journal-title":"Bioorg Med Chem Lett"},{"issue":"19","key":"6975_CR20","doi-asserted-by":"publisher","first-page":"7838","DOI":"10.1021\/jm500364u","volume":"57","author":"IM Bell","year":"2014","unstructured":"Bell IM (2014) Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine. J Med Chem 57(19):7838\u20137858. https:\/\/doi.org\/10.1021\/jm500364u","journal-title":"J Med Chem"},{"key":"6975_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6468(08)00201-4","volume":"47","author":"TM Williams","year":"2009","unstructured":"Williams TM, Burgey CS, Salvatore CA (2009) Calcitonin gene-related peptide receptor antagonists for the treatment of migraine. Prog Med Chem 47:1\u201335. https:\/\/doi.org\/10.1016\/S0079-6468(08)00201-4","journal-title":"Prog Med Chem"},{"key":"6975_CR22","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) Autodock vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"6975_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"6975_CR24","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM et al (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"6975_CR25","doi-asserted-by":"publisher","first-page":"100155","DOI":"10.1016\/j.insi.2025.100155","volume":"2","author":"D Devi","year":"2026","unstructured":"Devi D, Quasmi MN, Yeole K, Gupta P, Jangra A, Kumar D (2026) In silico repurposing of imeglimin against Alzheimer\u2019s disease using network pharmacology, molecular docking and molecular dynamic simulations approaches. In Silico Res Biomed 2:100155. https:\/\/doi.org\/10.1016\/j.insi.2025.100155","journal-title":"In Silico Res Biomed"},{"key":"6975_CR26","doi-asserted-by":"publisher","first-page":"100496","DOI":"10.1016\/j.chphi.2024.100496","volume":"8","author":"P Gupta","year":"2024","unstructured":"Gupta P, Panwar U, Singh S (2024) Novel scaffolds identification against Mpro of SARS-CoV-2 using shape based screening and molecular simulation methods. Chem Phys Impact 8:100496. https:\/\/doi.org\/10.1016\/j.chphi.2024.100496","journal-title":"Chem Phys Impact"},{"key":"6975_CR27","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"6975_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1021\/ml900016y","volume":"1","author":"IM Bell","year":"2010","unstructured":"Bell IM, Gallicchio SN, Wood MR, Quigley AG, Stump CA, Zartman CB, Fay JF, Li CC, Lynch JJ, Moore EL, Mosser SD, Prueksaritanont T, Regan CP, Roller S, Salvatore CA, Kane SA, Vacca JP, Selnick HG (2010) Discovery of MK-3207: a highly potent, orally bioavailable CGRP receptor antagonist. ACS Med Chem Lett 1:24\u201329. https:\/\/doi.org\/10.1021\/ml900016y","journal-title":"ACS Med Chem Lett"},{"key":"6975_CR29","doi-asserted-by":"publisher","first-page":"127624","DOI":"10.1016\/j.bmcl.2020.127624","volume":"31","author":"SE Mercer","year":"2021","unstructured":"Mercer SE, Chaturvedula PV, Conway CM, Cook DA, Davis CD, Pin SS, Macci R, Schartman R, Signor LJ, Widmann KA, Whiterock VJ, Chen P, Xu C, Herbst JJ, Kostich WA, Thalody G, Macor JE, Dubowchik GM (2021) Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists. Bioorg Med Chem Lett 31:127624. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127624","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.xphs.2021.06.034","volume":"111","author":"K Srinivasan","year":"2022","unstructured":"Srinivasan K, Kozminski K, Zhang Y, Wisniewski K, Kohout T, Wisniewska H, Harris G, Lindstrom B, Hargrove D (2022) Pharmacological, pharmacokinetic, pharmacodynamic and physicochemical characterization of FE 205030: a potent, fast acting, injectable CGRP receptor antagonist for the treatment of acute episodic migraine. J Pharm Sci 111:247\u2013261. https:\/\/doi.org\/10.1016\/j.xphs.2021.06.034","journal-title":"J Pharm Sci"},{"key":"6975_CR31","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1016\/j.bmcl.2012.05.118","volume":"22","author":"PV Chaturvedula","year":"2012","unstructured":"Chaturvedula PV, Pin S, Thalody G, Conway CM, Macor JE, Dubowchik GM (2012) Design and synthesis of potent antagonists containing rigid spirocyclic privileged structures for the CGRP receptor. Bioorg Med Chem Lett 22:4719\u20134722. https:\/\/doi.org\/10.1016\/j.bmcl.2012.05.118","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR32","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1016\/j.bmcl.2012.05.074","volume":"22","author":"X Han","year":"2012","unstructured":"Han X, Civiello RL, Conway CM, Cook DA, Davis CD, Macci R, Pin SS, Ren SX, Schartman R, Signor LJ, Thalody G, Widmann KA, Xu C, Chaturvedula PV, Macor JE, Dubowchik GM (2012) The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 1. Bioorg Med Chem Lett 22:4723\u20134727. https:\/\/doi.org\/10.1016\/j.bmcl.2012.05.074","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR33","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1016\/j.bmcl.2008.10.019","volume":"18","author":"CR Theberge","year":"2008","unstructured":"Theberge CR, Bednar RA, Bell IM, Corcoran HA, Fay JF, Hershey JC, Johnston VK, Kane SA, Mosser S, Salvatore CA, Williams TM, Zartman CB, Zhang XF, Graham SL, Vacca JP (2008) Potent benzimidazolone-based CGRP receptor antagonists. Bioorg Med Chem Lett 18:6122\u20136125. https:\/\/doi.org\/10.1016\/j.bmcl.2008.10.019","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR34","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1016\/j.bmcl.2015.07.021","volume":"25","author":"BM Crowley","year":"2015","unstructured":"Crowley BM, Stump CA, Nguyen DN, Potteiger CM, McWherter MA, Paone DV, Quigley AG, Bruno JG, Cui D, Culberson JC, Danziger A, Fandozzi C, Gauvreau D, Kemmerer AL, Menzel K, Moore EL, Mosser SD, Reddy V, White RB, Salvatore CA, Kane SA, Bell IM, Selnick HG, Fraley ME, Burgey CS (2015) Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine. Bioorg Med Chem Lett 25:4777\u20134781. https:\/\/doi.org\/10.1016\/j.bmcl.2015.07.021","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR35","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1016\/j.bmcl.2006.07.044","volume":"16","author":"CS Burgey","year":"2006","unstructured":"Burgey CS, Stump CA, Nguyen DN, Deng JZ, Quigley AG, Norton BR, Bell IM, Mosser SD, Salvatore CA, Rutledge RZ, Kane SA, Koblan KS, Vacca JP, Graham SL, Williams TM (2006) Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: optimization of the 4-substituted piperidine. Bioorg Med Chem Lett 16:5052\u20135056. https:\/\/doi.org\/10.1016\/j.bmcl.2006.07.044","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR36","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1016\/j.bmcl.2010.12.054","volume":"21","author":"DV Paone","year":"2011","unstructured":"Paone DV, Nguyen DN, Shaw AW, Burgey CS, Potteiger CM, Deng JZ, Mosser SD, Salvatore CA, Yu S, Roller S, Kane SA, Selnick HG, Vacca JP, Williams TM (2011) Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: discovery of MK-2918. Bioorg Med Chem Lett 21:2683\u20132686. https:\/\/doi.org\/10.1016\/j.bmcl.2010.12.054","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR37","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1016\/j.bmcl.2012.02.066","volume":"22","author":"G Luo","year":"2012","unstructured":"Luo G, Chen L, Pin SS, Xu C, Conway CM, Macor JE, Dubowchik GM (2012) Calcitonin gene-related peptide (CGRP) receptor antagonists: novel aspartates and succinates. Bioorg Med Chem Lett 22:2912\u20132916. https:\/\/doi.org\/10.1016\/j.bmcl.2012.02.066","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR38","doi-asserted-by":"publisher","first-page":"14294","DOI":"10.1074\/jbc.M109661200","volume":"277","author":"JJ Mallee","year":"2002","unstructured":"Mallee JJ, Salvatore CA, LeBourdelles B, Oliver KR, Longmore J, Koblan KS, Kane SA (2002) Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277:14294\u201314298. https:\/\/doi.org\/10.1074\/jbc.M109661200","journal-title":"J Biol Chem"},{"key":"6975_CR39","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1016\/j.bmcl.2009.07.134","volume":"19","author":"MR Wood","year":"2009","unstructured":"Wood MR, Schirripa KM, Kim JJ, Quigley AG, Stump CA, Bell IM, Bednar RA, Fay JF, Bruno JG, Moore EL, Mosser SD, Roller S, Salvatore CA, Kane SA, Vacca JP, Selnick HG (2009) Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility. Bioorg Med Chem Lett 19:5787\u20135790. https:\/\/doi.org\/10.1016\/j.bmcl.2009.07.134","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bmcl.2013.12.089","volume":"24","author":"P Joshi","year":"2014","unstructured":"Joshi P, Anderson C, Binch H, Hadida S, Yoo S, Bergeron D, Decker C, terHaar E, Moore J, Garcia-Guzman M, Termin A (2014) Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists. Bioorg Med Chem Lett 24:845\u2013849. https:\/\/doi.org\/10.1016\/j.bmcl.2013.12.089","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR41","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.bmcl.2010.02.086","volume":"20","author":"CA Stump","year":"2010","unstructured":"Stump CA, Bell IM, Bednar RA, Fay JF, Gallicchio SN, Hershey JC, Jelley R, Kreatsoulas C, Moore EL, Mosser SD, Quigley AG, Roller SA, Salvatore CA, Sharik SS, Theberge CR, Zartman CB, Kane SA, Graham SL, Selnick HG, Vacca JP, Williams TM (2010) Identification of potent, highly constrained CGRP receptor antagonists. Bioorg Med Chem Lett 20:2572\u20132576. https:\/\/doi.org\/10.1016\/j.bmcl.2010.02.086","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR42","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bmcl.2008.10.106","volume":"19","author":"CA Stump","year":"2009","unstructured":"Stump CA, Bell IM, Bednar RA, Bruno JG, Fay JF, Gallicchio SN, Johnston VK, Moore EL, Mosser SD, Quigley AG, Salvatore CA, Theberge CR, Blair Zartman C, Zhang XF, Kane SA, Graham SL, Vacca JP, Williams TM (2009) The discovery of highly potent CGRP receptor antagonists. Bioorg Med Chem Lett 19:214\u2013217. https:\/\/doi.org\/10.1016\/j.bmcl.2008.10.106","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1021\/ml300021s","volume":"3","author":"G Luo","year":"2012","unstructured":"Luo G, Chen L, Conway CM, Denton R, Keavy D, Gulianello M, Huang Y, Kostich W, Lentz KA, Mercer SE, Schartman R, Signor L, Browning M, Macor JE, Dubowchik GM (2012) Discovery of BMS-846372, a potent and orally active human CGRP receptor antagonist for the treatment of migraine. ACS Med Chem Lett 3:337\u2013341. https:\/\/doi.org\/10.1021\/ml300021s","journal-title":"ACS Med Chem Lett"},{"key":"6975_CR44","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1016\/j.bmcl.2012.04.105","volume":"22","author":"IM Bell","year":"2012","unstructured":"Bell IM, Stump CA, Gallicchio SN, Staas DD, Zartman CB, Moore EL, Sain N, Urban M, Bruno JG, Calamari A, Kemmerer AL, Mosser SD, Fandozzi C, White RB, Zrada MM, Selnick HG, Graham SL, Vacca JP, Kane SA, Salvatore CA (2012) MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats. Bioorg Med Chem Lett 22:3941\u20133945. https:\/\/doi.org\/10.1016\/j.bmcl.2012.04.105","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR45","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.1016\/j.bmcl.2011.09.056","volume":"21","author":"CB Zartman","year":"2011","unstructured":"Zartman CB, Bell IM, Gallicchio SN, Graham SL, Kane SA, Mallee JJ, Rutledge RZ, Salvatore CA, Vacca JP, Williams TM (2011) Identification of a novel RAMP-independent CGRP receptor antagonist. Bioorg Med Chem Lett 21:6705\u20136708. https:\/\/doi.org\/10.1016\/j.bmcl.2011.09.056","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bmcl.2013.11.027","volume":"24","author":"JJ Kim","year":"2014","unstructured":"Kim JJ, Wood MR, Stachel SJ, de Leon P, Nomland A, Stump CA, McWherter MA, Schirripa KM, Moore EL, Salvatore CA, Selnick HG (2014) (E)-Alkenes as replacements of amide bonds: development of novel and potent acyclic CGRP receptor antagonists. Bioorg Med Chem Lett 24:258\u2013261. https:\/\/doi.org\/10.1016\/j.bmcl.2013.11.027","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR47","doi-asserted-by":"publisher","first-page":"6827","DOI":"10.1016\/j.bmcl.2010.08.105","volume":"20","author":"MR Wood","year":"2010","unstructured":"Wood MR, Schirripa KM, Kim JJ, Bednar RA, Fay JF, Bruno JG, Moore EL, Mosser SD, Roller S, Salvatore CA, Vacca JP, Selnick HG (2010) Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality. Bioorg Med Chem Lett 20:6827\u20136830. https:\/\/doi.org\/10.1016\/j.bmcl.2010.08.105","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR48","doi-asserted-by":"publisher","first-page":"128077","DOI":"10.1016\/j.bmcl.2021.128077","volume":"43","author":"G Luo","year":"2021","unstructured":"Luo G, Jiang XJ, Chen L, Conway CM, Gulianello M, Kostich W, Keavy D, Signor LJ, Chen P, Davis C, Whiterock VJ, Schartman R, Widmann KA, Macor JE, Dubowchik GM (2021) Calcitonin gene-related peptide (CGRP) receptor antagonists: heterocyclic modification of a novel azepinone lead. Bioorg Med Chem Lett 43:128077. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128077","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR49","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.bmcl.2012.02.065","volume":"22","author":"G Luo","year":"2012","unstructured":"Luo G, Chen L, Civiello R, Pin SS, Xu C, Kostich W, Kelley M, Conway CM, Macor JE, Dubowchik GM (2012) Calcitonin gene-related peptide (CGRP) receptor antagonists: pyridine as a replacement for a core amide group. Bioorg Med Chem Lett 22:2917\u20132921. https:\/\/doi.org\/10.1016\/j.bmcl.2012.02.065","journal-title":"Bioorg Med Chem Lett"},{"key":"6975_CR50","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00894-009-0454-9","volume":"15","author":"E Durham","year":"2009","unstructured":"Durham E, Dorr B, Woetzel N, Staritzbichler R, Meiler J (2009) Solvent accessible surface area approximations for rapid and accurate protein structure prediction. J Mol Model 15:1093\u20131108. https:\/\/doi.org\/10.1007\/s00894-009-0454-9","journal-title":"J Mol Model"},{"key":"6975_CR51","doi-asserted-by":"publisher","first-page":"108425","DOI":"10.1016\/j.compbiolchem.2025.108425","volume":"117","author":"GAP Naik","year":"2025","unstructured":"Naik GAP, Paradkar O, Sharma V, Kumar S, Gupta P, Wadhwa P (2025) A computational journey in anticancer drug discovery: exploring AKT1 inhibition by novel oxadiazoles using molecular docking, ADMET, density functional theory and molecular dynamic simulation. Comput Biol Chem 117:108425. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108425","journal-title":"Comput Biol Chem"},{"key":"6975_CR52","doi-asserted-by":"publisher","unstructured":"Shinde DS, Qazi AF, Patil HR, Shukla R, Patil RD, Gupta P (2025) Green and tandem synthesis of heterocyclic \u03b1\u03b1\u2019-Dibromocycloamides and their target predictions and ADMET analysis. ChemistrySelect 10(16). https:\/\/doi.org\/10.1002\/slct.202501499","DOI":"10.1002\/slct.202501499"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06975-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-026-06975-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06975-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:03:25Z","timestamp":1792022605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-026-06975-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["6975"],"URL":"https:\/\/doi.org\/10.1007\/s00894-026-06975-2","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"419"}}